Study finds link between industry payments to oncologists and non-recommended cancer treatments

Patients with cancer whose oncologist receives payments from industry appear more likely to receive some non-recommended and low value treatments, finds a US study published by The BMJ today.

Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s

March 8, 2024

ArsenalBio secures $325m to develop cell therapy programmes

ArsenalBio’s pipeline comprises potential therapies being developed for treating solid tumours. Credit: shisu_ka/Shutterstock. ArsenalBio has closed an oversubscribed Series C financing round, securing $325m to

September 5, 2024

Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Despite considerable life-saving progress, cardiovascular diseases (CVDs) remain the leading cause of death globally, claiming an estimated 17.9 million lives each year.

February 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.